Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and HIV

pyrazines has been researched along with HIV in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, M; Huang, W; Li, X; Wu, X; Yu, F; Zhao, X1
Cheng, X; Daelemans, D; De Clercq, E; Ding, X; Dong, G; Gao, P; Liu, X; Menéndez-Arias, L; Pannecouque, C; Sun, L; Wang, X; Zhan, P; Zhang, X1
De Clercq, E1
Joyce, RM; Siddiqi, T1
Besa, E; Bray, P; Caro, J; Dulau Florea, A; Mahipal, A; Sbenghe, MM1
Chen, IW; Culberson, C; Ellis, JD; Embrey, MW; Felock, PJ; Fisher, TE; Gabryelski, LJ; Hazuda, DJ; Jin, L; Kim, B; Lyle, TA; Mallai, R; Schleif, WA; Staas, DD; Vacca, JP; Wai, JS; Williams, PD; Young, SD; Zhuang, L1

Reviews

1 review(s) available for pyrazines and HIV

ArticleYear
Curious (Old and New) Antiviral Nucleoside Analogues with Intriguing Therapeutic Potential.
    Current medicinal chemistry, 2015, Volume: 22, Issue:34

    Topics: Adenosine; Amides; Antiviral Agents; Deoxyadenosines; Ebolavirus; Hepacivirus; HIV; Humans; Nucleosides; Pyrazines

2015

Other Studies

5 other study(ies) available for pyrazines and HIV

ArticleYear
Synthesis of a Novel Class of 1,3-oxathiolane Nucleoside Derivatives of T- 705 and Evaluation of Their Anti-influenza A Virus and Anti-HIV Activity.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2018, Volume: 14, Issue:6

    Topics: Amides; Animals; Anti-HIV Agents; Dogs; HEK293 Cells; HIV; Humans; Influenza A Virus, H1N1 Subtype; Isomerism; Madin Darby Canine Kidney Cells; Nucleosides; Pyrazines; Ribavirin; Thiophenes

2018
5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
    European journal of medicinal chemistry, 2018, Jul-15, Volume: 155

    Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; HIV; HIV Integrase; HIV Integrase Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Pyrazines; Reverse Transcriptase Inhibitors; Ribonuclease H; Structure-Activity Relationship

2018
A case of HIV-negative primary effusion lymphoma treated with bortezomib, pegylated liposomal doxorubicin, and rituximab.
    Clinical lymphoma & myeloma, 2008, Volume: 8, Issue:5

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Doxorubicin; Herpesviridae Infections; Herpesvirus 8, Human; HIV; Humans; Immunohistochemistry; Liposomes; Lymphoma, Primary Effusion; Male; Positron-Emission Tomography; Pyrazines; Rituximab

2008
HHV-8-associated multicentric Castleman's disease in HIV-negative patient: a novel therapy for an orphan disease.
    The oncologist, 2012, Volume: 17, Issue:1

    Topics: Adult; Boronic Acids; Bortezomib; Castleman Disease; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV; Humans; Male; Pyrazines; Rare Diseases

2012
Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors.
    Bioorganic & medicinal chemistry letters, 2007, Oct-15, Volume: 17, Issue:20

    Topics: Animals; Benzene; Cell Line; HIV; HIV Integrase Inhibitors; Humans; Microsomes, Liver; Models, Molecular; Molecular Structure; Pyrazines; Rats; Structure-Activity Relationship; Virus Replication

2007